Published in Fed Proc on January 01, 1973
The class of surface immunoglobulin on cells carrying IgG memory in rat thoracic duct lymph: the size of the subpopulation mediating IgG memory. J Exp Med (1976) 1.32
Movement of IgG receptors on the lymphocyte surface induced by protein A of Staphylococcus aureus. Immunology (1974) 0.95
T cell-dependent helper and suppressive influences in an adoptive IgG antibody response. Immunology (1975) 0.85
Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease. Clin Exp Immunol (1976) 0.81
Lymphoid antigenic determinants of the chicken. Cellular representation and tissue localization. Immunology (1978) 0.78
Temporal evolution of the sensitivity to tetranitromethane of the active site of anti-Tobacco mosaic virus antibodies. Immunology (1975) 0.75
Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70
Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med (1974) 5.55
Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. J Exp Med (1971) 4.89
Synergy among lymphoid cells mediating the graft-versus-host response. II. Synergy in graft-versus-host reactions produced by Balb-c lymphoid cells of differing anatomic origin. J Exp Med (1970) 4.14
Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol (1968) 3.81
Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells. J Exp Med (1972) 3.77
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol (1976) 3.64
Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes. J Exp Med (1973) 3.50
Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. J Exp Med (1972) 3.32
Frequency of B lymphocytes responsive to anti-immunoglobulin. J Exp Med (1982) 3.30
Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol (1974) 3.27
Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro. J Exp Med (1976) 3.10
Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. J Exp Med (1974) 3.01
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
Immune responses in vitro. I. Cellular requirements for the immune response by nonprimed and primed spleen cells in vitro. J Exp Med (1969) 2.84
Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72
Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 2.43
Major urinary protein complex of normal mice: origin. Science (1965) 2.39
Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J Immunol (1981) 2.33
An Lyt differentiated thymocyte subpopulation detected by flow microfluorometry. Nature (1979) 2.29
Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice. J Exp Med (1970) 2.15
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol (1984) 1.95
Serum concentrations and allotypes of immunoglobulins in two lines of mice genetically selected for "high" or "low" antibody synthesis. J Exp Med (1970) 1.93
A hybridoma from an autoimmune NZB/NZW mouse producing monoclonal antibody to ribosomal-RNA. J Immunol (1980) 1.91
Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro. J Exp Med (1973) 1.83
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83
Characterization of the nonphagocytic adherent cell from the peritoneal cavity of normal and BCG-treated mice. J Immunol (1977) 1.77
Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. J Exp Med (1974) 1.77
Functional maturation of thymic lymphocyte populations in vitro. J Exp Med (1972) 1.76
IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76
Regulation of immune responses by suppressor T cells. Tohoku J Exp Med (1976) 1.73
B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin. J Exp Med (1976) 1.72
The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant Rev (1975) 1.64
Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med (1974) 1.64
Studies of thoracic duct lymphocytes of mice. I. Immunoglobulin synthesis in vitro. J Immunol (1968) 1.54
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54
The effects of heterologous anti-thymocyte sera in mice. I. The use of a graft-vs.-host assay as a measure of homograft reactivity. J Immunol (1968) 1.53
Immune response in vitro: independence of "activated" lymphoid cells. Science (1969) 1.52
Studies of thoracic duct lymphocytes of mice. II. A quantitative comparison of the capacity of thoracic duct lymphocytes and other lymphoid cells to induce graft-versus-host reactions. J Immunol (1970) 1.49
Experimental murine amyloid. IV. Amyloidosis and immunoglobulins. J Immunol (1969) 1.48
I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature (1982) 1.48
Immune responses in vitro. X. Functions of macrophages. J Immunol (1974) 1.47
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
Immune responses in vitro. II. Suppression of the immune response in vitro by specific antibody. J Exp Med (1969) 1.45
Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus. J Natl Cancer Inst (1973) 1.45
Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest (1970) 1.44
Establishment of B cell hybridomas with B cell surface antigens. J Immunol (1982) 1.44
Characteristics of BALB/C T cell lymphomas grown as continuous in vitro lines. J Immunol (1978) 1.42
Immune responses in vitro. V. Suppression of M, G, and A plaque-forming cell responses in cultures of primed mouse spleen cells by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 1.40
The immune response suppressed by specific antibody. Immunology (1969) 1.38
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med (1978) 1.37
Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J Immunol (1992) 1.35
Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med (1972) 1.32
T and B cells that recognize the same antigen do not transcribe similar heavy chain variable region gene segments. J Exp Med (1983) 1.31
Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells. J Immunol (1978) 1.30
Immune responses in vitro. VI. Cell interactions in the development of primary IgM, IgG and IgA plaque-forming cell responses in vitro. Cell Immunol (1973) 1.27
Secondary antibody responses in vitro to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X nonresponder)F1 spleen cells stimulated by parental GAT-macrophages. J Exp Med (1977) 1.26
Genetic factors controlling anti-sheep erythrocyte antibody response and immunoglobulin synthesis in backcross and F2 progeny of mice genetically selected for "high" or "low" antibody synthesis. J Exp Med (1972) 1.26
Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens. J Exp Med (1974) 1.24
Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.21
Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice. J Immunol (1987) 1.19
The effect of polyinosinic-polycytidylic acid upon graft-vs-host activity in BALB/c mice. J Immunol (1970) 1.18
Cell membrane IgD: demonstration of IgD on human lymphocytes by enzyme-catalyzed iodination and comparison with cell surface Ig of mouse, guinea pig, and rabbit. J Immunol (1976) 1.18
T cell regulation of isotype expression. The requirement for a second Ig-specific helper T cell population for the induction of IgG responses. Eur J Immunol (1981) 1.18
Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors. J Exp Med (1978) 1.16
Studies on the relative synthesis and distribution of IgA and IgG1 in various tissues and body fluids of the cow. J Immunol (1972) 1.16
Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol (1985) 1.14
Neonatal infection with mouse thymic virus. Differential effects on T cells mediating the graft-versus-host reaction. J Immunol (1976) 1.14
Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med (1984) 1.12
Differential binding of fluorescein-labeled lectins to mouse thymocytes: subsets revealed by flow microfluorometry. J Immunol (1980) 1.12
Activation of a suppressor T-cell pathway by interferon. Proc Natl Acad Sci U S A (1982) 1.10
Purification and analysis of isoforms of soluble immune response suppressor (SIRS). J Immunol (1985) 1.09
Genetic restriction of macrophage-lymphocyte interactions in secondary antibody responses in vitro. Cold Spring Harb Symp Quant Biol (1977) 1.09
Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III. J Exp Med (1979) 1.06
Three T cell hybridomas do not contain detectable heavy chain variable gene transcripts. J Exp Med (1983) 1.06
Modulation of immune responses by suppressor T cells. Fed Proc (1978) 1.05
Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol (1984) 1.04
The effects of heterologous anti-thymocyte sera in mice. 3. High susceptibility of germfree mice to the suppressive effects of IgG from rabbit anti-mouse thymocyte serum. J Exp Med (1969) 1.01
Antigen-specific suppressor T-cell activity in genetically restricted immune spleen cells. J Exp Med (1978) 1.00
Studies on human peripheral blood lymphocytes in vitro. V. Biosynthesis of immunoglobulins. J Immunol (1968) 1.00
The rodent malaria parasite Plasmodium yoelii lacks both types 1 and 2 T-independent antigens. J Immunol (1982) 0.99
X-linked B lymphocyte defect in CBA/N mice. IV. Cellular and environmental influences on the thymus dependent IgG anti-sheep red blood cell response. J Immunol (1979) 0.99
The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes. Eur J Immunol (1984) 0.99
Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages. J Immunol (1981) 0.98
Haplotype-specific suppression of antibody responses in vitro. I. Generation of genetically restricted suppressor T cells by neonatal treatment with semiallogeneic spleen cells. J Exp Med (1981) 0.98